Similarly, we have shown that a combination of PNPLA3 and TM6SF2 genotype along with a lipoprotein-derived assessment of insulin resistance was able to predict both NAFLD activity and fibrosis (unpublished data). Here, PNPLA3 is linked to Insulin resistance.